ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 44 filers reported holding ENOCHIAN BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,324 | +1653.4% | 59,804 | +122.3% | 0.00% | – |
| Q2 2023 | $15,246 | -89.8% | 26,908 | -83.5% | 0.00% | – |
| Q1 2023 | $149,667 | -9.9% | 163,553 | +1.4% | 0.00% | – |
| Q4 2022 | $166,052 | -38.7% | 161,216 | +7.8% | 0.00% | – |
| Q3 2022 | $271,000 | -7.5% | 149,536 | -1.6% | 0.00% | – |
| Q2 2022 | $293,000 | +32.0% | 152,008 | +464.9% | 0.00% | – |
| Q1 2022 | $222,000 | +13.3% | 26,908 | 0.0% | 0.00% | – |
| Q4 2021 | $196,000 | +3.7% | 26,908 | -4.3% | 0.00% | – |
| Q3 2021 | $189,000 | +35.0% | 28,103 | 0.0% | 0.00% | – |
| Q2 2021 | $140,000 | -73.8% | 28,103 | -81.4% | 0.00% | – |
| Q1 2021 | $534,000 | +12.4% | 150,779 | -6.2% | 0.00% | – |
| Q4 2020 | $475,000 | -23.5% | 160,762 | -7.2% | 0.00% | – |
| Q3 2020 | $621,000 | -2.1% | 173,321 | +15.0% | 0.00% | – |
| Q2 2020 | $634,000 | +16.8% | 150,679 | -16.8% | 0.00% | – |
| Q1 2020 | $543,000 | -31.9% | 181,136 | +14.1% | 0.00% | – |
| Q4 2019 | $797,000 | +193.0% | 158,701 | +220.9% | 0.00% | – |
| Q3 2019 | $272,000 | +455.1% | 49,452 | +351.3% | 0.00% | – |
| Q2 2019 | $49,000 | – | 10,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sciencast Management LP | 15,549 | $133,000 | 0.03% |
| CANTOR FITZGERALD, L. P. | 37,500 | $309,000 | 0.02% |
| 683 Capital Management, LLC | 37,368 | $308,000 | 0.02% |
| WEDBUSH SECURITIES INC | 13,000 | $107,000 | 0.01% |
| ExodusPoint Capital Management, LP | 51,127 | $422,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 15,965 | $129,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 71,291 | $588,000 | 0.00% |
| LMR Partners LLP | 16,767 | $138,000 | 0.00% |
| Ovata Capital Management Ltd | 300 | $2,000 | 0.00% |
| Qube Research & Technologies Ltd | 20,430 | $169,000 | 0.00% |